CCE-CBD-127

CASE INFORMATION

Case ID: MSC-2025-015
Case Name: Andrew Collins
Age: 48
Gender: Male
Indigenous Status: Non-Indigenous
Year: 2025
ICPC-2 Codes: L18 – Muscle symptom/complaint NOS

COMPETENCY OUTCOMES

Competency DomainCompetency Element
1. Communication and Consultation Skills1.1 Takes a detailed history to assess muscle symptoms and functional impact 1.2 Provides clear explanations of the diagnosis, investigations, and next steps
2. Clinical Information Gathering and Interpretation2.1 Conducts a systematic musculoskeletal and neurological examination 2.2 Identifies red flags requiring urgent referral
3. Diagnosis, Decision-Making and Reasoning3.1 Differentiates between common muscle complaints (e.g., myalgia, myopathy, inflammatory conditions) 3.2 Determines when further investigations (e.g., blood tests, imaging, specialist referral) are warranted
4. Clinical Management and Therapeutic Reasoning4.1 Develops an appropriate management plan, including lifestyle, pharmacological, and referral options 4.2 Ensures treatment is aligned with best-practice guidelines
5. Preventive and Population Health5.1 Provides education on risk factors for muscle conditions and preventive strategies
6. Professionalism6.1 Acknowledges patient concerns and maintains a patient-centred approach
7. General Practice Systems and Regulatory Requirements7.1 Ensures appropriate follow-up and safety-netting for muscle-related symptoms
9. Managing Uncertainty9.1 Recognises when further assessment or specialist referral is required
10. Identifying and Managing the Patient with Significant Illness10.1 Identifies serious conditions such as inflammatory myopathies, neurological disorders, or metabolic myopathies

CASE FEATURES

  • Middle-aged male presenting with muscle pain and weakness, requiring differentiation between benign vs serious neuromuscular conditions.
  • Comprehensive musculoskeletal and neurological examination.
  • Recognition of red flags, such as progressive weakness, myalgia with systemic symptoms, or neurological signs.
  • Management plan incorporating lifestyle, pharmacological, and referral pathways.
  • Addressing patient concerns about long-term prognosis and quality of life.

INSTRUCTIONS

Review the following patient record summary and scenario.

Your examiner will ask you a series of questions based on this information.

You have 15 minutes to complete this case.

The time for each question will be managed by the examiner.

The time allocation for each question is roughly as follows:

  • Question 1 – 3 minutes
  • Question 2 – 3 minutes
  • Question 3 – 3 minutes
  • Question 4 – 3 minutes
  • Question 5 – 3 minutes

PATIENT RECORD SUMMARY

Patient Details

Name: Andrew Collins
Age: 48
Gender: Male
Gender Assigned at Birth: Male
Indigenous Status: Non-Indigenous

Allergies and Adverse Reactions

  • Nil known

Medications

  • Atorvastatin 40mg daily
  • Metformin 1000mg BD

Past History

  • Type 2 diabetes mellitus (diagnosed 5 years ago, HbA1c 7.5%)
  • Hypertension (well controlled on perindopril 5mg daily)
  • Dyslipidaemia (on statin therapy for 3 years)

Social History

  • Works as a construction worker, physically demanding job
  • BMI 31 (obese)
  • Non-smoker
  • Drinks 6–8 standard drinks per week

Family History

  • Father had ischaemic heart disease at 60
  • No known family history of neuromuscular disorders

Smoking

  • Non-smoker

Alcohol

  • Drinks above recommended limits (6–8 standard drinks per week)

Vaccination and Preventative Activities

  • Up to date

SCENARIO

Andrew Collins, a 48-year-old construction worker, presents with generalised muscle pain and weakness over the past 3 months. The pain is worse in the thighs and shoulders, with difficulty climbing stairs and lifting objects.

He denies recent trauma, fever, joint swelling, or neurological symptoms such as numbness or tingling.

He has been on atorvastatin for dyslipidaemia for 3 years but reports no previous muscle issues.

He is worried about whether he has a serious muscle disease and asks if he needs further tests.

EXAMINATION FINDINGS

General Appearance: Well, slightly concerned
BMI: 31
Musculoskeletal Examination:

  • Proximal muscle weakness (shoulders, thighs), 4/5 strength
  • No significant joint swelling or tenderness
  • No muscle wasting, fasciculations, or cramps

Neurological Examination:

  • Reflexes: Normal and symmetrical
  • Sensation: Intact
  • Gait: Slightly slow, mild difficulty rising from a chair

EXAMINER ONLY INFORMATION

QUESTIONS

Q1. What are your differential diagnoses for Andrew’s muscle symptoms?

  • Prompt: What is the most likely diagnosis and why?
  • Prompt: What alternative conditions should be considered?

Q2. What red flags would indicate the need for urgent referral or further investigations?

  • Prompt: What features would suggest a serious neuromuscular disorder?
  • Prompt: What initial investigations would you consider?

Q3. How would you manage Andrew’s condition?

  • Prompt: What lifestyle and medication changes would you recommend?
  • Prompt: When would you consider referral to a specialist?

Q4. Andrew is concerned about having a serious muscle disease. How would you counsel him?

  • Prompt: How would you provide reassurance while ensuring appropriate follow-up?
  • Prompt: What support services or resources could you offer?

Q5. What preventive strategies can Andrew implement to reduce his risk of further muscle symptoms?

  • Prompt: How can he modify his lifestyle and medications to prevent recurrence?
  • Prompt: What role does exercise and dietary management play?

THE COMPETENT CANDIDATE

The competent candidate should be able to:

Q1: What are your differential diagnoses for Andrew’s muscle symptoms?

Andrew’s most likely diagnosis is statin-induced myopathy, given his proximal muscle weakness, history of atorvastatin use, and absence of neurological symptoms.

Key Differential Diagnoses:

  1. Statin-Induced Myopathy (Most Likely)Symmetric muscle pain and weakness, proximal limb involvement, with possible elevated CK.
  2. Polymyalgia Rheumatica (PMR) – Common in >50 years, presents with morning stiffness and proximal pain, often with elevated ESR/CRP.
  3. Inflammatory Myositis (Polymyositis/Dermatomyositis)Progressive weakness, possible skin rashes (in dermatomyositis), elevated CK/ANA/Mi-2 antibodies.
  4. Hypothyroid MyopathyFatigue, cold intolerance, bradycardia, with elevated TSH.
  5. Diabetic Neuropathy/Myopathy – Progressive weakness with sensory loss, usually distal involvement.

Further assessment, including blood tests (CK, TSH, inflammatory markers, and metabolic panel), is required to confirm the diagnosis.


Q2: What red flags would indicate the need for urgent referral or further investigations?

Red flags requiring urgent referral or investigation:

  • Severe muscle pain, dark urine (concern for rhabdomyolysis).
  • Rapidly progressive weakness, difficulty swallowing or breathing (concern for neuromuscular disorders or myositis).
  • Neurological signs (e.g., sensory loss, fasciculations, asymmetry) suggesting neuropathy or motor neuron disease.
  • Unexplained weight loss or systemic symptoms (concern for malignancy-related myopathy).

Recommended Investigations:

  • Creatine Kinase (CK) – Elevated in statin myopathy, myositis, and rhabdomyolysis.
  • TSH & Free T4 – Rule out hypothyroid myopathy.
  • ESR/CRP – Elevated in PMR, inflammatory myositis.
  • Electromyography (EMG) or MRI – If neuromuscular disease suspected.
  • Autoimmune Panel (ANA, Anti-Mi-2, Anti-Jo-1) – If inflammatory myositis suspected.

If rhabdomyolysis or myositis is suspected, urgent hospital referral is required.


Q3: How would you manage Andrew’s condition?

1. Immediate Steps:

  • Cease atorvastatin and reassess symptoms in 2–4 weeks.
  • Encourage hydration if mild myopathy, monitor for dark urine (rhabdomyolysis risk).

2. Pharmacological Management:

  • Consider switching to lower-dose statin or alternative lipid-lowering therapy (e.g., ezetimibe) if dyslipidaemia persists.
  • NSAIDs or paracetamol for symptom relief, if needed.

3. Lifestyle Modifications:

  • Weight reduction and dietary changes to improve metabolic health.
  • Regular, low-impact exercise to improve muscle strength.

4. Follow-Up and Specialist Referral:

  • Review in 4 weeks, recheck CK and symptoms.
  • If symptoms persist despite statin withdrawal, refer to neurology/rheumatology for further assessment.

Management should focus on minimising cardiovascular risk while balancing muscle health.


Q4: Andrew is concerned about having a serious muscle disease. How would you counsel him?

  1. Acknowledge and Address Concerns
    • “It’s understandable to be worried, but most cases of muscle pain with statins resolve after stopping the medication.”
  2. Explain the Likely Diagnosis
    • “Your symptoms are consistent with statin-induced myopathy, which is common and usually reversible.”
  3. Discuss Next Steps and Monitoring
    • “We will stop your statin, monitor your symptoms, and consider an alternative approach if needed.”
    • “If your symptoms don’t improve, we will do further testing to rule out other conditions.”
  4. Provide Reassurance and Follow-Up Plan
    • “I will review you in 4 weeks to assess progress and adjust your treatment plan if needed.”

Empathetic communication ensures patient engagement and reduces anxiety.


Q5: What preventive strategies can Andrew implement to reduce his risk of further muscle symptoms?

  1. Optimising Medication Use:
    • Use lowest effective dose of statins to reduce risk.
    • Consider non-statin alternatives (ezetimibe, PCSK9 inhibitors).
  2. Lifestyle Modifications:
    • Reduce alcohol intake (6–8 drinks/week is above recommended limits).
    • Increase physical activity with low-impact resistance training.
    • Weight loss (target BMI <25).
  3. Regular Health Monitoring:
    • Routine CK monitoring if symptoms recur with statin reintroduction.
    • Annual cardiovascular risk assessment.
  4. Dietary Considerations:
    • Increase omega-3 intake (fish, nuts, flaxseeds).
    • Reduce processed food and sugar intake to improve metabolic health.

Long-term muscle health depends on optimised statin use, lifestyle changes, and regular monitoring.


SUMMARY OF A COMPETENT ANSWER

  • Comprehensive differential diagnosis, considering statin myopathy, myositis, endocrine causes, and neuromuscular disorders.
  • Identification of red flags, ensuring urgent investigations if needed.
  • Structured evidence-based management plan, including statin withdrawal, symptom monitoring, and alternative lipid-lowering therapy.
  • Clear patient-centred counselling, addressing concerns about muscle disease and ensuring follow-up.
  • Preventive strategies, including lifestyle changes, medication review, and exercise guidance.

PITFALLS

  • Failing to assess for serious conditions, missing rhabdomyolysis, inflammatory myositis, or neuropathy.
  • Continuing statin therapy despite clear symptoms, leading to progression of muscle damage.
  • Overlooking lifestyle factors, such as alcohol use, diet, and weight.
  • Not considering alternative lipid-lowering options, leading to poor cardiovascular risk management.
  • Lack of structured follow-up, missing progression of symptoms or treatment failure.

REFERENCES


MARKING

Each competency area is on the following scale from 0 to 3.

☐ Competency NOT demonstrated
☐ Competency NOT CLEARLY demonstrated
☐ Competency SATISFACTORILY demonstrated
☐ Competency FULLY demonstrated

1. Communication and Consultation Skills

1.1 Takes a detailed history to assess muscle symptoms and functional impact.
1.2 Provides clear explanations of the diagnosis, investigations, and next steps.

2. Clinical Information Gathering and Interpretation

2.1 Conducts a systematic musculoskeletal and neurological examination.
2.2 Identifies red flags requiring urgent referral.

3. Diagnosis, Decision-Making and Reasoning

3.1 Differentiates between common muscle complaints.
3.2 Determines when further investigations are warranted.

4. Clinical Management and Therapeutic Reasoning

4.1 Develops an appropriate management plan, including lifestyle, pharmacological, and referral options.
4.2 Ensures treatment is aligned with best-practice guidelines.

5. Preventive and Population Health

5.1 Provides education on risk factors for muscle conditions and preventive strategies.

6. Professionalism

6.1 Acknowledges patient concerns and maintains a patient-centred approach.

Competency at Fellowship Level

☐ CLEARLY BELOW STANDARD
☐ BELOW EXPECTED STANDARD
☐ BORDERLINE
☐ AT EXPECTED STANDARD
☐ ABOVE STANDARD